找回密码
 立即注册

微信扫码登录

搜索

[NCCN胸膜间皮瘤] 治疗前评估(PM-2)

[复制链接]
阳光肺科 发表于 2026-6-26 18:34:39 | 显示全部楼层 |阅读模式

马上注册,阅读更多内容,享用更多功能!

您需要 登录 才可以下载或查看,没有账号?立即注册

×
治疗前评估;临床I期且组织学为上皮样患者的非手术评估;临床II-IV期且组织学为上皮样、组织学为肉瘤样或双相型(任何阶段),或者医学上无法手术患者的治疗(PM-2)
202607270350551624.jpg

临床I期且组织学为上皮样患者的手术评估和治疗(PM-3)  

c Principles of Pathologic Review (PM-A).
d Best supportive care is recommended for patients presenting with performance status (PS) 3–4. See Principles of Supportive Care and Survivorship (PM-B).
e Principles of Systemic Therapy (PM-C).
f Pleural intensity-modulated radiation therapy (IMRT) should only be performed in carefully selected patients at centers with experience in this technique. See Principles
of Radiation Therapy (PM-D).
g Observation may be considered for patients who are asymptomatic with minimal burden of disease if systemic therapy is planned at the time of symptomatic or
radiographic progression.
h The benefit of surgical resection in pleural mesothelioma is unclear and there is no evidence that patient survival is improved with surgery when combined with
systemic therapy versus systemic therapy alone.
i Principles of Supportive Care and Survivorship (PM-B).


NCCN恶性胸膜间皮瘤指南导航
 楼主| 阳光肺科 发表于 2026-6-26 18:34:47 | 显示全部楼层
游客,您所在的用户组(游客)暂无权限查看回复内容,请微信注册本站

给我们建议|手机版|阳光肺科 ( 粤ICP备2020077405号-1 )

GMT+8, 2026-7-29 05:56

Powered by Discuz! X3.5

© 2001-2026 Discuz! Team.

快速回复 返回顶部 返回列表